Company Profile
MoonLake Immunotherapeutics Stock Price, News & Analysis
- Ticker:
- MLTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, MoonLake Immunotherapeutics is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates.
Stock performance
21.22 USD (-4.24%)
Close
Last updated: June 23, 2026 at 00:00
1.56B USD
Market cap
Why the stock is moving
MLTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
MoonLake Immunotherapeutics is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, MoonLake Immunotherapeutics is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates.
Business Model Characteristics
MoonLake Immunotherapeutics is a pipeline-led immunology story, so the market tends to track readouts, regulatory milestones, and how the company expands from one immune program to the next.
Position Within the Biotechnology Landscape
Compared with more mature peers, MoonLake Immunotherapeutics sits close to the development side of the biotech landscape, where immunology data can change sentiment quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
Source: MoonLake Immunotherapeutics
- 02
MoonLake Immunotherapeutics Announces Proposed Public Offering
Source: MoonLake Immunotherapeutics
- 03
- 04
- 05
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
Source: MoonLake Immunotherapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MoonLake Immunotherapeutics (MLTX)?
MoonLake Immunotherapeutics (MLTX) most recently closed at 21.22 USD, a -4.24% move versus the previous session.
What is the market cap of MoonLake Immunotherapeutics (MLTX)?
MoonLake Immunotherapeutics currently has a market capitalization of 1.56B USD on BioPharmSignal.
What does MoonLake Immunotherapeutics do?
MoonLake Immunotherapeutics is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
On which exchange is MLTX stock listed?
MoonLake Immunotherapeutics (MLTX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, MoonLake Immunotherapeutics is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates., Biotechnology.
What is MoonLake?
MoonLake Immunotherapeutics is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
Which conditions is MoonLake Immunotherapeutics targeting with MoonLake?
MoonLake Immunotherapeutics is associated with immunology based on its company overview and current catalyst commentary.
What is Immunotherapeutics?
MoonLake Immunotherapeutics is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.